Back to Massachusetts

H4332 • 2025

An Act relative to pharmacists as healthcare providers

An Act relative to pharmacists as healthcare providers

Healthcare
Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Financial Services (J)
Last action
2026-03-19
Official status
Referred to Joint Committee on Health Care Financing
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act relative to pharmacists as healthcare providers

An Act relative to pharmacists as healthcare providers Status: Referred to Joint Committee on Health Care Financing

What This Bill Does

  • An Act relative to pharmacists as healthcare providers Status: Referred to Joint Committee on Health Care Financing

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-19 House

    Reporting date extended to Monday, June 15, 2026

  2. 2025-12-08 House

    Reporting date extended to Wednesday, March 18, 2026

  3. 2025-07-31 House

    Reported from the committee on Financial Services

  4. 2025-07-31 House

    New draft of H1091

  5. 2025-07-31 House

    Reported favorably by committee and referred to the committee on Health Care Financing

Official Summary Text

An Act relative to pharmacists as healthcare providers
Status:
Referred to Joint Committee on Health Care Financing

Current Bill Text

Read the full stored bill text
×

Bill H.4332

Chapter 94C is hereby amended by inserting, after section 19F, the following section:-

Section 19G. (a) Notwithstanding any general or special law to the contrary, a pharmacist may order, test, screen, and treat the following health conditions: influenza, streptococcal infections, COVID-19 or any other emerging and existing public health threats identified by the department if permitted by an order, rule, or regulation.

b) The department shall establish standard procedures for pharmacists to test, screen and initiate treatment for qualified health conditions.

(c) A pharmacist who orders, tests, screens, or treats health conditions under this section may use any test that may guide clinical decision making that is waived under the federal Clinical Laboratory Improvement Amendments of 1988, or the federal rules adopted thereunder, or any established screening procedure that is established via a statewide protocol.

(d) A pharmacist may delegate the administrative and technical tasks of performing a test waived by the federal Clinical Laboratory Improvement Amendments of 1988 to a pharmacy technician acting under the supervision of the pharmacist.

(e) This section prohibits the denial of reimbursement under health benefit plans for services and procedures performed by a pharmacist that are within the scope of the pharmacist’s license and would be covered if the services or procedures were performed by a physician, an advanced practice nurse, or physician's assistant. An insurance carrier or pharmacy benefit manager shall develop adequate provider and consult codes as authorized by this act for pharmacy compensation.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close